MedTrace Logo

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

NCT01946009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-06-29

No results posted yet for this study

Summary

Cidofovir could be an effective drug for the treatment of Anal Intraepithelial Neoplasia(AIN).

Conditions

Interventions

DRUG

Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.

Sponsors & Collaborators

  • Fundacion SEIMC-GESIDA

    lead OTHER

Principal Investigators

  • Elena Sendagorta, MD · Hospital La Paz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946009 on ClinicalTrials.gov